<DOC>
	<DOCNO>NCT01219842</DOCNO>
	<brief_summary>Peripheral arterial disease ( PAD ) often cause exertion pain leg , intermittent claudication ( CI ) affect &gt; 10 % individual &gt; 65 year . A recent Swedish Health Technology Assessment Report identify limited evidence effectiveness invasive treatment IC patient already exercise training . The prognosis extremity usually benign treatment therefore aim improve quality life . Invasive treatment also cause serious complication . Coronary artery disease common IC patient increase risk invasive treatment . In spite uncertain merit potential risk , invasive procedure IC increase 37 % invasive procedure PAD Sweden perform IC . The aim study evaluate additional effect modern invasive treatment patient intermittent claudication receive modern best medical treatment ( BMT ) . The primary hypothesis study invasive treatment addition BMT improve health relate quality life walk performance compare BMT .</brief_summary>
	<brief_title>Invasive Revascularization Not Intermittent Claudication</brief_title>
	<detailed_description />
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>Patient intermittent claudication ( typical symptom ABI &lt; 0.9 ) seek treatment Significant aortoiliac and/or femoropopliteal lesion . Age 3080 year Invasive treatment contraindicate severe intercurrent disease . Two fail vascular reconstruction leg . Employees unable work intermittent claudication . Need open reconstruction tibioperoneal trunc . Thromboembolic etiology ( popliteal artery aneurysm ; cardiac embolus ) Other disease severely affect walk performance . Body weight &gt; 120 kilogram . Age &lt; 30 &gt; 80 year .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Intermittent claudication</keyword>
	<keyword>Health Related Quality Life</keyword>
	<keyword>Walking performance</keyword>
	<keyword>Daily walking capacity</keyword>
</DOC>